MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 421 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $14,000 | -22.2% | 230 | -42.8% | 0.00% | 0.0% |
| Q1 2016 | $18,000 | -95.3% | 402 | -95.0% | 0.00% | -96.1% |
| Q4 2015 | $386,000 | +11.6% | 7,989 | -1.8% | 0.05% | +4.1% |
| Q3 2015 | $346,000 | -49.6% | 8,135 | +17.2% | 0.05% | -60.5% |
| Q3 2014 | $686,000 | +12.1% | 6,939 | -12.6% | 0.12% | +3.3% |
| Q2 2014 | $612,000 | +36.9% | 7,940 | +14.4% | 0.12% | +16.5% |
| Q1 2014 | $447,000 | +39.3% | 6,940 | +38.0% | 0.10% | +21.2% |
| Q4 2013 | $321,000 | – | 5,028 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |